Anticancer agent 180

• Description :

  Anticancer agent 180 (compound 4) is a secondary metabolite induced by co-culture of fungi and actinomycetes, the later one can produce HDAC inhibitors Trichostatins. Anticancer agent 180 has potential anti-tumor activity and can inhibit the migration of MDA-MB-231 breast cancer cells[1].

• CAS Number :

  [9007-83-4]

• UNSPSC :

  12352005

• Target :

  Endogenous Metabolite

• Type :

  Natural Products

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/anticancer-agent-180.html

• Solubility :

  10 mM in DMSO

• Smiles :

  OC(C(C1=CC=C(C=C1)O)=CN(C)C2=O)=C2[C@@]3([H])O[C@](CCC(CC(CC)C)C)([H])CCC3

• Molecular Formula :

  C26H37NO4

• Molecular Weight :

  427.58

• References & Citations :

  [1]Hwang GJ, et al. Induction of Fungal Secondary Metabolites by Co-Culture with Actinomycete Producing HDAC Inhibitor Trichostatins. J Microbiol Biotechnol. 2023 Nov 28;33 (11) :1437-1447.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported